FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2474570215> ?p ?o ?g. }

• W2474570215 endingPage "2080" @default.
• W2474570215 startingPage "2069" @default.
• W2474570215 abstract "Rheumatic disease is not a single disorder, but a group of more than 100 diseases that affect joints, connective tissues, and/or internal organs. Although rheumatic diseases like rheumatoid arthritis (RA), psoriatic arthritis, and ankylosing spondylitis (AS) differ in their pathogenesis and clinical presentation, the treatment of these inflammatory disorders overlaps. Non-steroid anti-inflammatory drugs are used to reduce pain and inflammation. Additional disease-modifying anti-rheumatic drugs are prescribed to slowdown disease progression, and is in RA more frequently and effectively applied than in AS. Biologicals are a relatively new class of treatments that specifically target cytokines or cells of the immune system, like tumor necrosis factor alpha inhibitors or B-cell blockers. A new kid on the block is the interleukin-17 (IL-17) inhibitor secukinumab, which has been recently approved by the US Food and Drug Administration for moderate-to-severe plaque psoriasis, psoriatic arthritis, and AS. IL-17 is a proinflammatory cytokine that has an important role in host defense, but its proinflammatory and destructive effects have also been linked to pathogenic processes in autoimmune diseases like RA and psoriasis. Animal models have greatly contributed to further insights in the potential of IL-17 blockade in autoimmune and autoinflammatory diseases, and have resulted in the development of various potential drugs targeting the IL-17 pathway. Secukinumab (AIN457) is a fully human monoclonal antibody that selectively binds to IL-17A and recently entered the market under the brand name Cosentyx(®). By binding to IL-17A, secukinumab prevents it from binding to its receptor and inhibits its ability to trigger inflammatory responses that play a role in the development of various autoimmune diseases. With secukinumab being the first in class to receive Food and Drug Administration approval, this article will further focus on this new biologic agent and review the milestones in its development and marketing." @default.
• W2474570215 created "2016-07-22" @default.
• W2474570215 creator A5033347806 @default.
• W2474570215 creator A5045199963 @default.
• W2474570215 date "2016-06-01" @default.
• W2474570215 modified "2023-10-14" @default.
• W2474570215 title "Secukinumab for rheumatology: development and its potential place in therapy" @default.
• W2474570215 cites W1483788981 @default.
• W2474570215 cites W1495088797 @default.
• W2474570215 cites W1504831700 @default.
• W2474570215 cites W1508752722 @default.
• W2474570215 cites W1526073830 @default.
• W2474570215 cites W1537128240 @default.
• W2474570215 cites W1553271826 @default.
• W2474570215 cites W1576647157 @default.
• W2474570215 cites W1597241561 @default.
• W2474570215 cites W1622605727 @default.
• W2474570215 cites W1779605851 @default.
• W2474570215 cites W1784308670 @default.
• W2474570215 cites W1911161962 @default.
• W2474570215 cites W1935617463 @default.
• W2474570215 cites W1961692905 @default.
• W2474570215 cites W1973040111 @default.
• W2474570215 cites W1973354423 @default.
• W2474570215 cites W1982926364 @default.
• W2474570215 cites W1987628377 @default.
• W2474570215 cites W1987772124 @default.
• W2474570215 cites W1989065194 @default.
• W2474570215 cites W1993328396 @default.
• W2474570215 cites W1994182162 @default.
• W2474570215 cites W2003678590 @default.
• W2474570215 cites W2004186675 @default.
• W2474570215 cites W2014785961 @default.
• W2474570215 cites W2018320089 @default.
• W2474570215 cites W2020233428 @default.
• W2474570215 cites W2023017226 @default.
• W2474570215 cites W2029437196 @default.
• W2474570215 cites W2033342396 @default.
• W2474570215 cites W2043654224 @default.
• W2474570215 cites W2049448291 @default.
• W2474570215 cites W2051713867 @default.
• W2474570215 cites W2061952215 @default.
• W2474570215 cites W2076889715 @default.
• W2474570215 cites W2078428843 @default.
• W2474570215 cites W2080390872 @default.
• W2474570215 cites W2083340757 @default.
• W2474570215 cites W2092602103 @default.
• W2474570215 cites W2095017027 @default.
• W2474570215 cites W2095753163 @default.
• W2474570215 cites W2096020283 @default.
• W2474570215 cites W2102591216 @default.
• W2474570215 cites W2103524303 @default.
• W2474570215 cites W2104079854 @default.
• W2474570215 cites W2107235439 @default.
• W2474570215 cites W2107332711 @default.
• W2474570215 cites W2108373994 @default.
• W2474570215 cites W2108984264 @default.
• W2474570215 cites W2110031819 @default.
• W2474570215 cites W2110555227 @default.
• W2474570215 cites W2110826367 @default.
• W2474570215 cites W2112128505 @default.
• W2474570215 cites W2112133235 @default.
• W2474570215 cites W2112723784 @default.
• W2474570215 cites W2113633952 @default.
• W2474570215 cites W2115779634 @default.
• W2474570215 cites W2116537360 @default.
• W2474570215 cites W2116828514 @default.
• W2474570215 cites W2118706017 @default.
• W2474570215 cites W2120393706 @default.
• W2474570215 cites W2120989550 @default.
• W2474570215 cites W2121385382 @default.
• W2474570215 cites W2122980756 @default.
• W2474570215 cites W2124551692 @default.
• W2474570215 cites W2125573161 @default.
• W2474570215 cites W2128119287 @default.
• W2474570215 cites W2132784721 @default.
• W2474570215 cites W2135808113 @default.
• W2474570215 cites W2136357996 @default.
• W2474570215 cites W2142017607 @default.
• W2474570215 cites W2148251534 @default.
• W2474570215 cites W2151280501 @default.
• W2474570215 cites W2151440511 @default.
• W2474570215 cites W2158174717 @default.
• W2474570215 cites W2158854771 @default.
• W2474570215 cites W2158998079 @default.
• W2474570215 cites W2159212884 @default.
• W2474570215 cites W2159788225 @default.
• W2474570215 cites W2160883911 @default.
• W2474570215 cites W2164521956 @default.
• W2474570215 cites W2173317407 @default.
• W2474570215 cites W2194197257 @default.
• W2474570215 cites W2216248217 @default.
• W2474570215 cites W2278932593 @default.
• W2474570215 cites W2326643498 @default.
• W2474570215 cites W2405224982 @default.
• W2474570215 cites W4210768724 @default.
• W2474570215 cites W4210968471 @default.
• W2474570215 cites W182672931 @default.

• next